Relationship of Atrial Fibrillation and N Terminal Pro Brain Natriuretic Peptide in Heart Failure Patients
ESC Heart Failure · 01.12.2023 · 10 (6) · 3250-3257
DOI: 10.1002/ehf2.14542 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ESC Heart Failure, online erschienen am 30.09.2023. Verfasst von Entezar Nasab Mehrabi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, School of Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
N terminal pro brain natriuretic peptide (NT-proBNP) plays an important role in the diagnosis and prognosis of heart failure (HF). The plasma level of NT-proBNP in atrial fibrillation (AF) patients was higher than of sinus rhythm patients. In HF, NT-proBNP levels are affected by the concomitant presence of AF, making it difficult to distinguish between HF and AF in patients with elevated NT-proBNP. Several other diseases, such as renal failure and pulmonary embolism, are known to further increase NT-proBNP levels in patients with concomitant HF. Therefore, NT-proBNP is a sensitive but non-specific marker for the detection of HF. AF is very important in this regard because among patients with HF regardless of ejection fraction, symptoms such as shortness of breath and atrial enlargement develop and can mimic HF. In the present study, we investigated whether the prognostic value of natriuretic peptides in HF holds true for patients with concomitant AF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, School of Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Cardiology, School of Medicine, Valiasr Hospital, Zanjan University of Medical Sciences, Zanjan, Iran.
- Department of Cardiology, School of Medicine, Ayatollah Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran.
- Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Zitieren
APA
Nasab Mehrabi, E., Toupchi-Khosroshahi, V., & Athari, S. S. (2023). Relationship of Atrial Fibrillation and N Terminal Pro Brain Natriuretic Peptide in Heart Failure Patients. ESC Heart Failure, 10(6), 3250-3257. https://doi.org/10.1002/ehf2.14542
Vancouver
Nasab Mehrabi E, Toupchi-Khosroshahi V, Athari SS. Relationship of Atrial Fibrillation and N Terminal Pro Brain Natriuretic Peptide in Heart Failure Patients. ESC Heart Failure. 2023;10(6):3250-3257. doi:10.1002/ehf2.14542
BibTeX
@article{NasabMehrabi2023,
author = {Nasab Mehrabi, Entezar and Toupchi-Khosroshahi, Vahid and Athari, Seyyed Shamsadin},
title = {Relationship of Atrial Fibrillation and N Terminal Pro Brain Natriuretic Peptide in Heart Failure Patients},
journal = {ESC Heart Failure},
year = {2023},
volume = {10},
number = {6},
pages = {3250--3257},
doi = {10.1002/ehf2.14542}
}
EUVIMED